Skip to content

Trial Comparing Electric and Harmonic Scalpel in Mastectomy

Prospective Trial Comparing the Use of Conventional Electric Scalpel and Harmonic Scalpel in Mastectomy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01391988
Acronym
Harmonic
Enrollment
97
Registered
2011-07-12
Start date
2008-01-31
Completion date
2008-11-30
Last updated
2014-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication, Postoperative

Brief summary

Prospective trial comparing post-operative complications and seroma formation after mastectomy in patients with breast cancer, using conventional electric scalpel and harmonic scalpel.

Detailed description

The population of this study was formed by women aged older than 18 years old, with breast carcinoma (ductal ou lobular) at any stage, form whom modified radical mastectomy is proposed. Patients were excluded if the present blood dyscrasia, collagen diseases, known uncontrolled chronic disease, infections (mammary or axillary, ulcerated tumors and pregnancy. The women were submitted to modified radical mastectomy consecutive allocated in electric scalpel group and the other group with harmonic scalpel. Electric scalpels were calibrated at 40 watts of cutting and coagulation power and harmonic scalpel with a GEN04 generator calibrated at power levels 3 and 5, using the HP054 handpiece and HF105 curved blade. Local postoperative complications analysed were seroma, hematoma, skin necrosis and infection.

Interventions

PROCEDUREElectric scalpel

Radical mastectomy with electric scalpel. Electric scalpels were calibrated at 40 watts of cutting and coagulation power.

Radical mastectomy with harmonic scalpel. Harmonic GEN04 generator calibrated at power leve 3 and 5, using the HP054 handpiece and HF 105 curved blade

Sponsors

Barretos Cancer Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Women with breast cancer candidate to a radical mastectomy during the year of 2008. Prospective trial with women stratified consecutive. Inclusion Criteria: * Breast carcinoma (ductal or lobular) * Modified radical mastectomy was the surgery to be realized

Exclusion criteria

* Not inclusion criteria * Blood dyscrasia, collagen diseases, known uncontrolled chronic diseases, infections (mammary or axillary), ulcerated tumors and pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Differences in operative conditions and first week seroma drainage1 week.Time of the surgery and blood loss volume during surgery. Drain volume postoperative in the first week

Secondary

MeasureTime frameDescription
Differences in local complicationday 7 and day 14Number of participants with adverse events as seroma, hematoma, skin necrosis and infection

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026